Dr. Yarur is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8730 Alden Dr. Thalians 2E
Los Angeles, CA 90048Phone+1 414-955-6830Fax+1 414-955-6214
Summary
- Dr. Andres Yarur is a gastroenterologist at the IBD center of Cedars Sinai Medical Center. He received his medical degree from University of Miami Leonard M. Miller School of Medicine and has been in practice 14 years. Performs clinical and translational research in Crohn's disease and ulcerative colitis while caring for patients with these chronic conditions.
Education & Training
University of ChicagoFellowship, Gastroenterology, 2017
University of Miami/Jackson Health SystemFellowship, Gastroenterology, 2011 - 2014- University of Miami/Jackson Health SystemResidency, Internal Medicine, 2008 - 2011
University of Miami Leonard M. Miller School of MedicineClass of 2006
Certifications & Licensure
CA State Medical License 2022 - 2026
WI State Medical License 2015 - 2023
IL State Medical License 2014 - 2020
FL State Medical License Active through 2014
American Board of Internal Medicine Gastroenterology
Clinical Trials
- Vedolizumab Monotherapy Vs Combination Therapy With Tacrolimus in UC Start of enrollment: 2017 May 18
Publications & Presentations
PubMed
- Real-World Effectiveness and Safety of Upadacitinib in Crohn's disease: A Multi-Centre Study.Jalpa Devi, Anthony Xu, Molly Stone, Anish Patel, Abdul Khan
Clinical Gastroenterology and Hepatology. 2025-03-07 - Efficacy and Safety of Etrasimod in Patients With Moderately to Severely Active Ulcerative Colitis Stratified by Baseline Modified Mayo Score: A Post Hoc Analysis From...Bruce E Sands, Marla C Dubinsky, Paulo G Kotze, Séverine Vermeire, Remo Panaccione
Inflammatory Bowel Diseases. 2025-02-28 - Ustekinumab Drug Clearance Is Better Associated with Disease Control than Serum Trough Concentrations in a Prospective Cohort of Inflammatory Bowel Disease.Andres J Yarur, Thierry Dervieux, Ryan Ungaro, Elizabeth A Spencer, Alexandra Bruss
Pharmaceutics. 2025-02-02
Journal Articles
- Vedolizumab Concentrations Are Associated with Long-Term Endoscopic Remission in Patients with Inflammatory Bowel DiseasesRyan Ungaro, Daniel J Stein, Andres J Yarur, Amir Patel, Marla Dubinsky, Digestive Diseases and Sciences
Press Mentions
$3M Grant Awarded to Examine Ozempic Effect on Crohn's DiseaseDecember 13th, 2024- Helmsley Charitable Trust Awards $3 Million Grant to Research Epithelial Healing in Crohn’s DiseaseDecember 12th, 2024
- Cedars-Sinai Experts Share Advances in Gastroenterology Care at ACG 2024October 25th, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
